Tofacitnib Citrate

Tsanangudzo Pfupi

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP
Tofacitnib Citrate Rheumatoid arthritis Mumba      


Product Detail

Product Tags

PRODUCT DETAIL

Background

Tofacitinib citrate, inozivikanwawo seCP-690550 citrate, inhibitor ine simba yejanus kinase 3 (JAK3), hematopoetic cell-inodzorwa tyrosine kinase inobatanidzwa mukufambiswa kwechiratidzo inodzora kupona kwelymphocyte, kupararira, kusiyanisa, uye apoptosis.Iyo inhibition ndeye JAK3 chaiyo ine selectivity 1000-yakapetwa kupfuura mamwe asiri eJAK mhuri kinases.Kunze kwekudzivisa JAKS (IC50 = 1 nM), tofacitinib citrate inodzivisawo janus kinase 2 (JAK2) uye janus kinase 1 (JAK1) ine 20- uye 100-fold zvishoma mu potency maererano.Nekudaro, muongororo ichangoburwa, iyo inosunga affinities (Ki) ye tofacitinib citrate yakanangana neJAK1, JAK2, uye JAK3 yakanzi 1.6 nM, 21.7 nM, uye 6.5 nM zvakateerana.

Reference

Lalitha Vijayakrishnan, R. Venkataramanan and Palak Gulati.Kurapa kuzvimba nejanus kinase inhibitor CP-690,550.Maitiro muPharmacological Sayenzi 2011: 32 (1);25-34

Product Citation

  • 1. Panagi I, Jennings E, et al."Salmonella Effector SteE Inoshandura iyo Mammalian Serine/Threonine Kinase GSK3 kuita Tyrosine Kinase kuDirect Macrophage Polarization."Cell Host Microbe.2020;27(1):41–53.e6.PMID:31862381
  • 2. McInnes IB, Byers NL, nevamwe."Kuenzanisa kwe baricitinib, upadacitinib, uye tofacitinib yakapindirana mutemo we cytokine kuisa chiratidzo muvanhu leukocyte subpopulations."Arthritis Res Ther.2019 Aug 2;21(1):183.PMID:31375130
  • 3. Liu S, Verma M, nevamwe."Steroid resistance ye airway type 2 innate lymphoid masero kubva kuvarwere vane asthma yakaoma: Basa re thymic stromal lymphopoietin." J Allergy Clin Immunol.2018 Jan;141(1):257-268.e6.PMID:28433687
  • 4. Zheng, Lufeng, nevamwe."Iyo 3' UTR yepseudogene CYP4Z2P inokurudzira tumor angiogenesis mukenza yemazamu nekuita se ceRNA yeCYP4Z1."Tsvakurudzo yekenza yemazamu uye kurapwa (2015): 1-14.PMID:25701119

Tsanangudzo

Tofacitinib citrate inowanika nemuromo JAK1/2/3 inhibitor ine IC50s ye1, 20, uye 112 nM, zvichiteerana.Tofacitinib citrate ine antibacterial, antifungal uye antiviral mabasa.

Storage

4°C, chengetedza kubva kuchiedza

*In solvent : -80°C, 6 mwedzi;-20°C, 1 mwedzi (dzivirira kubva kuchiedza)

 

Chimiro chemakemikari

Tofacitnib Citrate

Related Biological Data

Tofacitnib Citrate2

Related Biological Data

Tofacitnib Citrate3

Related Biological Data

Tofacitnib Citrate4

Related Biological Data

Tofacitnib Citrate5

Related Biological Data

Tofacitnib Citrate6

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

HUNHU MANAGEMENT

Quality management1

Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.

Quality management2

Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.

Quality management3

Kutariswa kwemhando yepamusoro kunofamba kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando nekurapa.

Quality management4

Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.

KUTUNGAMIRIRA KWEKUGARA

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kudyidzana kwenyika dzose
International cooperation
Kushandira pamwe kwemumba
Domestic cooperation

  • Zvakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano uye utumire kwatiri